Literature DB >> 18823699

EMP3 as a tumor suppressor gene for esophageal squamous cell carcinoma.

Shoichi Fumoto1, Keiko Hiyama, Keiji Tanimoto, Takuya Noguchi, Jun Hihara, Eiso Hiyama, Tsuyoshi Noguchi, Masahiko Nishiyama.   

Abstract

EMP3, epithelial membrane protein 3, was recently reported to be a tumor suppressor gene in neuroblastomas and gliomas. We found that EMP3 was commonly repressed in esophageal squamous cell carcinoma (ESCC) cell lines by oligonucleotide microarrays. Its overexpression in ESCC cell lines caused growth inhibition with morphological changes and TERT repression. In addition to promoter hypermethylation, TSA caused repression of EMP3, indicating the involvement of histone deacetylase-regulated repressors. The post-recurrent survival after radical surgery was poorer in ESCC patients with lower EMP3 expression. We propose that EMP3 may be a tumor suppressor gene at the late step of ESCC carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18823699     DOI: 10.1016/j.canlet.2008.08.021

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  11 in total

Review 1.  Review of the GAS3 Family of Proteins and their Relevance to Cancer.

Authors:  Negin Ashki; Lynn Gordon; Madhuri Wadehra
Journal:  Crit Rev Oncog       Date:  2015

2.  Expression of epithelial membrane protein (EMP) 1, EMP 2, and EMP 3 in thyroid cancer.

Authors:  Eun Kyung Kim; Ja Seung Koo
Journal:  Histol Histopathol       Date:  2021-10-07       Impact factor: 2.303

3.  Expression and Role of Epithelial Membrane Proteins in Tumorigenesis of Hormone Receptor-Positive Breast Cancer.

Authors:  Yoon Jin Cha; Ja Seung Koo
Journal:  J Breast Cancer       Date:  2020-07-30       Impact factor: 3.588

4.  Gene expression analysis of zebrafish melanocytes, iridophores, and retinal pigmented epithelium reveals indicators of biological function and developmental origin.

Authors:  Charles W Higdon; Robi D Mitra; Stephen L Johnson
Journal:  PLoS One       Date:  2013-07-09       Impact factor: 3.240

5.  Targeting EMP3 suppresses proliferation and invasion of hepatocellular carcinoma cells through inactivation of PI3K/Akt pathway.

Authors:  Yi-Hsien Hsieh; Shu-Ching Hsieh; Chien-Hsing Lee; Shun-Fa Yang; Chun-Wen Cheng; Meng-Ju Tang; Chia-Liang Lin; Chu-Liang Lin; Ruey-Hwang Chou
Journal:  Oncotarget       Date:  2015-10-27

6.  EMP3 negatively modulates breast cancer cell DNA replication, DNA damage repair, and stem-like properties.

Authors:  Kailing Zhou; Yu Sun; Dan Dong; Chenghai Zhao; Wei Wang
Journal:  Cell Death Dis       Date:  2021-09-12       Impact factor: 8.469

7.  Promoter hypermethylation of the EMP3 gene in a series of 229 human gliomas.

Authors:  Marta Mellai; Angela Piazzi; Valentina Caldera; Laura Annovazzi; Oriana Monzeglio; Rebecca Senetta; Paola Cassoni; Davide Schiffer
Journal:  Biomed Res Int       Date:  2013-09-03       Impact factor: 3.411

Review 8.  Promoter methylation of tumor suppressor genes in esophageal squamous cell carcinoma.

Authors:  Ji-Sheng Li; Jian-Ming Ying; Xiu-Wen Wang; Zhao-Hui Wang; Qian Tao; Li-Li Li
Journal:  Chin J Cancer       Date:  2012-05-08

9.  Epithelial membrane protein 3 regulates TGF-β signaling activation in CD44-high glioblastoma.

Authors:  Fu Jun; Jidong Hong; Qin Liu; Yong Guo; Yiwei Liao; Jianghai Huang; Sailan Wen; Liangfang Shen
Journal:  Oncotarget       Date:  2017-02-28

10.  Epithelial membrane protein 1 promotes tumor metastasis by enhancing cell migration via copine-III and Rac1.

Authors:  Mohammad Khusni B Ahmat Amin; Akio Shimizu; Dimitar P Zankov; Akira Sato; Souichi Kurita; Masami Ito; Toshinaga Maeda; Tetsuya Yoshida; Tomohisa Sakaue; Shigeki Higashiyama; Akihiro Kawauchi; Hisakazu Ogita
Journal:  Oncogene       Date:  2018-06-04       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.